Rammekontrakt om levering af MFR-vaccine 2026 – 2030

TENDER DESCRIPTION

The framework agreement concerns the supply of MMR vaccine (measles, mumps, rubella vaccine) in the period 2026 – 2030. It is a requirement that the offered vaccine at the time of submission of the tender has a marketing authorization valid for Denmark, cf. the Medicines Act § 7, subsection 1. Further requirements for the vaccine are specified in the tender documents. It is estimated that the need for purchasing MMR vaccines is approximately 130,000 – 150,000 doses annually, i.e. a total estimated quantity of approximately 520,000 – 600,000 doses over the term of the framework agreement. The purpose of the framework agreement is to ensure that SSI can make the necessary purchase of the covered vaccines for the public vaccination program in accordance with the expected need for such vaccines during the framework agreement period of up to 48 months. Purchases under the agreement depend on the decisions made for the public vaccination program and on vaccination coverage. Thus, a significant variation in the annually estimated consumption can be expected. Considering this and that the total need for vaccines may vary considerably depending on which decisions are made for the…

TENDER BRIEF

TENDER DOCUMENTS